© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 12, 977-986,
June 21, 2000
© 2000 Oxford University Press
EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer
Affiliations of authors: N. van Zandwijk, O. Dalesio, H. van Tinteren, The Netherlands Cancer Institute, Amsterdam; U. Pastorino, European Institute of Oncology, Milan, Italy; N. de Vries, St. Lucas Hospital, Amsterdam.
Correspondence to: Nico van Zandwijk, M.D., Ph.D., The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands (e-mail: zandwijk{at}nki.nl).
Background: Preclinical evidence suggests that retinoids and antioxidants may prevent or delay the occurrence of cancer in the upper or lower airways, but such effects have not been reliably established in clinical studies. To assess the chemopreventive effects of vitamin A (retinyl palmitate) and N-acetylcysteine, we conducted a large randomized intervention study in patients with head and neck cancer or with lung cancer, most of whom had a history of smoking. Methods: From June 1988 through July 1994, a total of 2592 patients (60% with head and neck cancer and 40% with lung cancer) were randomly assigned to receive 1) retinyl palmitate (300000 IU daily for 1 year followed by 150000 IU for a 2nd year), 2) N-acetylcysteine (600 mg daily for 2 years), 3) both compounds, or 4) no intervention. All statistical tests were two-sided. Results: Of the patients, 93.5% had smoked tobacco at sometime in their lives (and 25% continued to smoke after cancer diagnosis). After a median follow-up of 49 months, 916 patients were reported with an event (recurrence, second primary tumor, or death). No statistically significant difference was observed in overall survival or event-free survival between patients who received retinyl palmitate and patients who did not. Similarly, no difference was seen in overall survival or event-free survival between patients who received N-acetylcysteine and patients who did not. There was a lower incidence of second primary tumors in the no intervention arm, but the difference was not statistically significant. Conclusion: A 2-year supplementation of retinyl palmitate and/or N-acetylcysteine resulted in no benefit—in terms of survival, event-free survival, or second primary tumors—for patients with head and neck cancer or with lung cancer, most of whom were previous or current smokers.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. J. Wirth, J. F. Krane, Y. Li, M. Othus, A. E. Moran, D. M. Dorfman, C. M. Norris Jr, L. Goguen, M. R. Posner, R. I. Haddad, et al. A Pilot Surrogate Endpoint Biomarker Study of Celecoxib in Oral Premalignant Lesions Cancer Prevention Research, October 1, 2008; 1(5): 339 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. N. Hittelman, D. D. Liu, J. M. Kurie, R. Lotan, J. S. Lee, F. Khuri, H. Ibarguen, R. C. Morice, G. Walsh, J. A. Roth, et al. Proliferative Changes in the Bronchial Epithelium of Former Smokers Treated With Retinoids J Natl Cancer Inst, November 7, 2007; 99(21): 1603 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gray, J. T. Mao, E. Szabo, M. Kelley, J. Kurie, and G. Bepler Lung Cancer Chemoprevention: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 56S - 68S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Davies, G. Davey Smith, R. Harbord, G. E. Bekkering, J. A. C. Sterne, R. Beynon, and S. Thomas Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review. J Natl Cancer Inst, July 19, 2006; 98(14): 961 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. El-Bayoumy, A. Das, B. Narayanan, N. Narayanan, E. S. Fiala, D. Desai, C. V. Rao, S. Amin, and R. Sinha Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer Carcinogenesis, July 1, 2006; 27(7): 1369 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Kelloff, S. M. Lippman, A. J. Dannenberg, C. C. Sigman, H. L. Pearce, B. J. Reid, E. Szabo, V. C. Jordan, M. R. Spitz, G. B. Mills, et al. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward Clin. Cancer Res., June 15, 2006; 12(12): 3661 - 3697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Khuri, J. J. Lee, S. M. Lippman, E. S. Kim, J. S. Cooper, S. E. Benner, R. Winn, T. F. Pajak, B. Williams, G. Shenouda, et al. Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients. J Natl Cancer Inst, April 5, 2006; 98(7): 441 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Sabichi, X. Xu, and S. M. Lippman RAR{beta}1': Primed To Fight Retinoid Resistance in Lung Carcinogenesis J Natl Cancer Inst, November 16, 2005; 97(22): 1632 - 1633. [Full Text] [PDF]
|
|
|
|
 |
|
 F. R. Hirsch and S. M. Lippman Advances in the Biology of Lung Cancer Chemoprevention J. Clin. Oncol., May 10, 2005; 23(14): 3186 - 3197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Kim and W. K. Hong An Apple a Day...Does It Really Keep the Doctor Away? The Current State of Cancer Chemoprevention J Natl Cancer Inst, April 6, 2005; 97(7): 468 - 470. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Witschi Carcinogenic Activity of Cigarette Smoke Gas Phase and Its Modulation by Beta-Carotene and N-Acetylcysteine Toxicol. Sci., March 1, 2005; 84(1): 81 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Perry, M. Stevens, I. Rabie, M.-E. Yarker, J. Cochrane, E. Perry, R. Traficante, and W. Coman Chemoprevention of Head and Neck Cancer With Retinoids: A Negative Result Arch Otolaryngol Head Neck Surg, March 1, 2005; 131(3): 198 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Lefebvre Current clinical outcomes demand new treatment options for SCCHN Ann. Onc., January 1, 2005; 16(suppl_6): vi7 - vi12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sudbo Novel Management of Oral Cancer: A Paradigm of Predictive Oncology Clin. Med. Res., November 1, 2004; 2(4): 233 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Khuri and R. Lotan Retinoids in Lung Cancer: Friend, Foe, or Fellow Traveler? J. Clin. Oncol., September 1, 2004; 22(17): 3435 - 3437. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Kim, H. Lee, H. Kim, Y. M. Shim, J. Han, J. Park, and D.-H. Kim Promoter Methylation of Retinoic Acid Receptor Beta 2 and the Development of Second Primary Lung Cancers in Non-Small-Cell Lung Cancer J. Clin. Oncol., September 1, 2004; 22(17): 3443 - 3450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Keith, Y. E. Miller, T. M. Hudish, C. E. Girod, S. Sotto-Santiago, W. A. Franklin, R. A. Nemenoff, T. H. March, S. P. Nana-Sinkam, and M. W. Geraci Pulmonary Prostacyclin Synthase Overexpression Chemoprevents Tobacco Smoke Lung Carcinogenesis in Mice Cancer Res., August 15, 2004; 64(16): 5897 - 5904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Khuri and V. Cohen Molecularly Targeted Approaches to the Chemoprevention of Lung Cancer Clin. Cancer Res., June 15, 2004; 10(12): 4249S - 4253S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Rhee, F. R. Khuri, and D. M. Shin Advances in Chemoprevention of Head and Neck Cancer Oncologist, June 1, 2004; 9(3): 302 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Tsao, E. S. Kim, and W. K. Hong Chemoprevention of Cancer CA Cancer J Clin, May 1, 2004; 54(3): 150 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Winterhalder, F. R. Hirsch, G. K. Kotantoulas, W. A. Franklin, and P. A. Bunn Jr Chemoprevention of lung cancer--from biology to clinical reality Ann. Onc., February 1, 2004; 15(2): 185 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al. American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003 J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353. [Full Text] [PDF]
|
|
|
|
|
|
C. M. Rudin, E. E.W. Cohen, V. A. Papadimitrakopoulou, S. Silverman Jr, W. Recant, A. K. El-Naggar, K. Stenson, S. M. Lippman, W. K. Hong, and E. E. Vokes An Attenuated Adenovirus, ONYX-015, As Mouthwash Therapy for Premalignant Oral Dysplasia J. Clin. Oncol., December 15, 2003; 21(24): 4546 - 4552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M Myhre, M. H Carlsen, S. K Bohn, H. L Wold, P. Laake, and R. Blomhoff Water-miscible, emulsified, and solid forms of retinol supplements are more toxic than oil-based preparations Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1152 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Means-Markwell, R. I. Linnoila, J. Williams, P. A. Janne, F. Kaye, K. O'Neil, and B. E. Johnson Prospective Study of the Airways and Pulmonary Parenchyma of Patients at Risk for a Second Lung Cancer Clin. Cancer Res., December 1, 2003; 9(16): 5915 - 5921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Zhang, W. C. Willett, J. Selhub, J. E. Manson, G. A. Colditz, and S. E. Hankinson A Prospective Study of Plasma Total Cysteine and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1188 - 1193. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Rice, H.-W. Kim, A. Sabichi, S. Lippman, J. J. Lee, B. Williams, A. Vaporciyan, W. R. Smythe, S. Swisher, G. Walsh, et al. The risk of second primary tumors after resection of Stage I nonsmall cell lung cancer Ann. Thorac. Surg., October 1, 2003; 76(4): 1001 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Chun, J. W. Kosmeder II, S. Sun, J. M. Pezzuto, R. Lotan, W. K. Hong, and H.-Y. Lee Effects of Deguelin on the Phosphatidylinositol 3-Kinase/Akt Pathway and Apoptosis in Premalignant Human Bronchial Epithelial Cells J Natl Cancer Inst, February 19, 2003; 95(4): 291 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nyska, A. Suttie, S. Bakshi, L. Lomnitski, S. Grossman, M. Bergman, V. Ben-Shaul, P. Crocket, J. K. Haseman, G. Moser, et al. Slowing Tumorigenic Progression in TRAMP Mice and Prostatic Carcinoma Cell Lines Using Natural Anti-Oxidant from Spinach, NAO--A Comparative Study of Three Anti-Oxidants Toxicol Pathol, January 1, 2003; 31(1): 39 - 51. [Abstract] [PDF]
|
|
|
|
 |
|
 G E Goodman Lung cancer * 1: Prevention of lung cancer Thorax, November 1, 2002; 57(11): 994 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, P. Upadhyaya, M. Wang, R. L. Bliss, E. J. McIntee, and P. M.J. Kenney Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination Carcinogenesis, September 1, 2002; 23(9): 1455 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Witschi, I. Espiritu, S. T. Dance, and M. S. Miller A Mouse Lung Tumor Model of Tobacco Smoke Carcinogenesis Toxicol. Sci., August 1, 2002; 68(2): 322 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Monnerat, S. Faivre, S. Temam, J. Bourhis, and E. Raymond End points for new agents in induction chemotherapy for locally advanced head and neck cancers Ann. Onc., July 1, 2002; 13(7): 995 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Malins, K. E. Hellstrom, K. M. Anderson, P. M. Johnson, and M. A. Vinson Antioxidant-induced changes in oxidized DNA PNAS, April 18, 2002; (2002) 82111199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Van Schooten, A. Besarati Nia, S. De Flora, F. D'Agostini, A. Izzotti, A. Camoirano, A. J. M. Balm, J. W. Dallinga, A. Bast, G. R. M. M. Haenen, et al. Effects of Oral Administration of N-Acetyl-L-cysteine: A Multi-Biomarker Study in Smokers Cancer Epidemiol. Biomarkers Prev., February 1, 2002; 11(2): 167 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Witschi, I. Espiritu, M. Suffia, and K. E. Pinkerton Expression of cyclin D1/2 in the lungs of strain A/J mice fed chemopreventive agents Carcinogenesis, February 1, 2002; 23(2): 289 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman and M. R. Spitz Lung Cancer Chemoprevention: An Integrated Approach J. Clin. Oncol., September 15, 2001; 19(90001): 74s - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Pastorino Molecular Targeting: the New Challenge in Lung Cancer Prevention J Natl Cancer Inst, August 15, 2001; 93(16): 1190 - 1191. [Full Text] [PDF]
|
|
|
|
|
|
F. R. Khuri, E. S. Kim, J. J. Lee, R. J. Winn, S. E. Benner, S. M. Lippman, K. K. Fu, J. S. Cooper, E. E. Vokes, R. M. Chamberlain, et al. The Impact of Smoking Status, Disease Stage, and Index Tumor Site on Second Primary Tumor Incidence and Tumor Recurrence in the Head and Neck Retinoid Chemoprevention Trial Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 823 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Szabo Lung Epithelial Proliferation: a Biomarker for Chemoprevention Trials? J Natl Cancer Inst, July 18, 2001; 93(14): 1042 - 1043. [Full Text] [PDF]
|
|
|
|
|
|
J. J. Lee, D. Liu, J. S. Lee, J. M. Kurie, F. R. Khuri, H. Ibarguen, R. C. Morice, G. Walsh, J. Y. Ro, A. Broxson, et al. Long-Term Impact of Smoking on Lung Epithelial Proliferation in Current and Former Smokers J Natl Cancer Inst, July 18, 2001; 93(14): 1081 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. De Flora, A. Izzotti, F. D'Agostini, and R. M. Balansky Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points Carcinogenesis, July 1, 2001; 22(7): 999 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Shin, F. R. Khuri, B. Murphy, A. S. Garden, G. Clayman, M. Francisco, D. Liu, B. S. Glisson, L. Ginsberg, V. Papadimitrakopoulou, et al. Combined Interferon-Alfa, 13-cis-Retinoic Acid, and Alpha-Tocopherol in Locally Advanced Head and Neck Squamous Cell Carcinoma: Novel Bioadjuvant Phase II Trial J. Clin. Oncol., June 15, 2001; 19(12): 3010 - 3017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman, J. J. Lee, D. D. Karp, E. E. Vokes, S. E. Benner, G. E. Goodman, F. R. Khuri, R. Marks, R. J. Winn, W. Fry, et al. Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer J Natl Cancer Inst, April 18, 2001; 93(8): 605 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Khuri, J. S. Lee, S. M. Lippman, J. J. Lee, S. Kalapurakal, R. Yu, J. Y. Ro, R. C. Morice, W. K. Hong, and W. N. Hittelman Modulation of Proliferating Cell Nuclear Antigen in the Bronchial Epithelium of Smokers Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 311 - 318. [Abstract] [Full Text]
|
|
|
|
|
|
S. T. Mayne, B. Cartmel, M. Baum, G. Shor-Posner, B. G. Fallon, K. Briskin, J. Bean, T. Zheng, D. Cooper, C. Friedman, et al. Randomized Trial of Supplemental {beta}-Carotene to Prevent Second Head and Neck Cancer Cancer Res., February 1, 2001; 61(4): 1457 - 1463. [Abstract] [Full Text]
|
|
|
|
|
|
G. S. Omenn Chemoprevention of Lung Cancer Is Proving Difficult and Frustrating, Requiring New Approaches J Natl Cancer Inst, June 21, 2000; 92(12): 959 - 960. [Full Text] [PDF]
|
|
|
|
|
|
D. C. Malins, K. E. Hellstrom, K. M. Anderson, P. M. Johnson, and M. A. Vinson Antioxidant-induced changes in oxidized DNA PNAS, April 30, 2002; 99(9): 5937 - 5941. [Abstract] [Full Text] [PDF]
|
|